Titan Cement International S.A. (TITC)
Athens Exchange · Greece · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 47.58 |
|---|---|
| 52-week range | 38.20 – 59.00 |
| Return, 1 month / 3 months | −3.7% / −5.2% |
| Return, 1 year / 3 years | +21.4% / +188.2% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 30.9% |
| Worst drawdown (1 year) | -26.0% |
| Average daily value traded | 4.23M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Titan Cement International is a building materials group based in Greece. It makes cement, aggregates and ready-mixed concrete, and supplies related products for construction work. Its customers are builders, contractors and distributors who use these materials in infrastructure, commercial and residential projects. The company runs production facilities and serves construction markets in Greece and in a number of other countries, so its business spans several regions rather than a single local market.
The shares are listed on the Athens Exchange in Greece under the code TITC, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Titan Cement International S.A. (TITC) trades on the Athens Exchange in Greece. It last closed at EUR 47.58 on 23 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 69 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.4% and over the last three months it fell 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.6% | ||
| From 52-week high | -19.1% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.2% | ||
| 6-month return | 1.4% | ||
| 12-month return, skipping the last month | 26.0% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.0% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 4.23M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −1.3% |
|---|---|
| 1 month | −3.7% |
| 3 months | −5.2% |
| 6 months | +1.4% |
| 1 year | +21.4% |
| 3 years | +188.2% |
| 5 years | +248.7% |
Signals
| 50-day / 200-day average | 49.84 / 50.41 |
|---|---|
| Golden / death cross (60 days) | Death, 7 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.01 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Jun 2023 | EUR 0.4200 |
| 27 Apr 2022 | EUR 0.3500 |
| 28 Apr 2021 | EUR 0.2800 |
| 13 May 2020 | EUR 0.1400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.